Cargando…

Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2

BACKGROUND: The decrease of IL-2 level is believed to play an important role in the disease occurrence and development of SLE, but the relevant mechanisms have not been fully clarified. Many studies have found that the level of soluble interleukin 2 receptor α (sIL-2Rα) in SLE patients is significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Dan, Yu, Shujiao, Zhang, Lu, Guo, Yang, Xu, Shumin, Rao, Yuting, Huang, Zikun, Luo, Qing, Li, Junming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531682/
https://www.ncbi.nlm.nih.gov/pubmed/36203602
http://dx.doi.org/10.3389/fimmu.2022.938556
_version_ 1784801952636338176
author Long, Dan
Yu, Shujiao
Zhang, Lu
Guo, Yang
Xu, Shumin
Rao, Yuting
Huang, Zikun
Luo, Qing
Li, Junming
author_facet Long, Dan
Yu, Shujiao
Zhang, Lu
Guo, Yang
Xu, Shumin
Rao, Yuting
Huang, Zikun
Luo, Qing
Li, Junming
author_sort Long, Dan
collection PubMed
description BACKGROUND: The decrease of IL-2 level is believed to play an important role in the disease occurrence and development of SLE, but the relevant mechanisms have not been fully clarified. Many studies have found that the level of soluble interleukin 2 receptor α (sIL-2Rα) in SLE patients is significantly increased. Considering the fact that sIL-2Rα has the ability to bind IL-2, we want to know whether the increased sIL-2Rα has some impact on the level and function of IL-2 in SLE patients. METHODS: New onset SLE patients, treated SLE patients and healthy volunteers were recruited. The levels of serum IL-2, IL-2 mRNA in CD3(+) T cells and serum sIL-2Rα were detected and compared in these subjects. Two mixed solid-phase sandwich ELISA system were designed to measure exclusively the heterodimers complex of sIL-2Rα/IL-2. The sera from SLE patients were pretreated with or without immune complex dissociation solution and detected for IL-2 levels. IL-2 standard or serum from HCs were used to co-incubate with recombinant sIL-2Rα or serum samples with high levels of sIL-2Rα and detected for IL-2 levels by ELISA. The inhibitory effect of sIL-2Rα on IL-2 biological activity was investigated by CTLL-2 cell proliferation assay. The frequencies and absolute counts of Treg cells were detected by flow cytometry before and after the addition of recombinant sIL-2Rα. RESULTS: The levels of serum IL-2 in SLE patients were significantly decreased and negatively correlated with SLEDAI. However, there was no significant difference in IL-2 mRNA levels in CD3(+) T cells between SLE patients and healthy controls. The levels of serum sIL-2Rα in SLE patients were significantly increased, positively correlated with the SLEDAI and negatively correlated with the levels of serum IL-2. sIL-2Rα was shown to bind to IL-2 to form immune complex, resulting in false reduction in the detection level of serum IL-2 and significant decrease in biological activity of IL-2. The increase of sIL-2Rα was demonstrated to be one of the important mechanisms for the obstruction of Treg cells differentiation in SLE patients. CONCLUSION: Increased serum sIL-2Rα can bind to IL-2, leading to obstruction of IL-2 activity and Treg cells differentiation.
format Online
Article
Text
id pubmed-9531682
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95316822022-10-05 Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2 Long, Dan Yu, Shujiao Zhang, Lu Guo, Yang Xu, Shumin Rao, Yuting Huang, Zikun Luo, Qing Li, Junming Front Immunol Immunology BACKGROUND: The decrease of IL-2 level is believed to play an important role in the disease occurrence and development of SLE, but the relevant mechanisms have not been fully clarified. Many studies have found that the level of soluble interleukin 2 receptor α (sIL-2Rα) in SLE patients is significantly increased. Considering the fact that sIL-2Rα has the ability to bind IL-2, we want to know whether the increased sIL-2Rα has some impact on the level and function of IL-2 in SLE patients. METHODS: New onset SLE patients, treated SLE patients and healthy volunteers were recruited. The levels of serum IL-2, IL-2 mRNA in CD3(+) T cells and serum sIL-2Rα were detected and compared in these subjects. Two mixed solid-phase sandwich ELISA system were designed to measure exclusively the heterodimers complex of sIL-2Rα/IL-2. The sera from SLE patients were pretreated with or without immune complex dissociation solution and detected for IL-2 levels. IL-2 standard or serum from HCs were used to co-incubate with recombinant sIL-2Rα or serum samples with high levels of sIL-2Rα and detected for IL-2 levels by ELISA. The inhibitory effect of sIL-2Rα on IL-2 biological activity was investigated by CTLL-2 cell proliferation assay. The frequencies and absolute counts of Treg cells were detected by flow cytometry before and after the addition of recombinant sIL-2Rα. RESULTS: The levels of serum IL-2 in SLE patients were significantly decreased and negatively correlated with SLEDAI. However, there was no significant difference in IL-2 mRNA levels in CD3(+) T cells between SLE patients and healthy controls. The levels of serum sIL-2Rα in SLE patients were significantly increased, positively correlated with the SLEDAI and negatively correlated with the levels of serum IL-2. sIL-2Rα was shown to bind to IL-2 to form immune complex, resulting in false reduction in the detection level of serum IL-2 and significant decrease in biological activity of IL-2. The increase of sIL-2Rα was demonstrated to be one of the important mechanisms for the obstruction of Treg cells differentiation in SLE patients. CONCLUSION: Increased serum sIL-2Rα can bind to IL-2, leading to obstruction of IL-2 activity and Treg cells differentiation. Frontiers Media S.A. 2022-09-20 /pmc/articles/PMC9531682/ /pubmed/36203602 http://dx.doi.org/10.3389/fimmu.2022.938556 Text en Copyright © 2022 Long, Yu, Zhang, Guo, Xu, Rao, Huang, Luo and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Long, Dan
Yu, Shujiao
Zhang, Lu
Guo, Yang
Xu, Shumin
Rao, Yuting
Huang, Zikun
Luo, Qing
Li, Junming
Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title_full Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title_fullStr Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title_full_unstemmed Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title_short Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2
title_sort increased sil-2rα leads to obstruction of il-2 biological function and treg cells differentiation in sle patients via binding to il-2
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531682/
https://www.ncbi.nlm.nih.gov/pubmed/36203602
http://dx.doi.org/10.3389/fimmu.2022.938556
work_keys_str_mv AT longdan increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT yushujiao increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT zhanglu increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT guoyang increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT xushumin increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT raoyuting increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT huangzikun increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT luoqing increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2
AT lijunming increasedsil2raleadstoobstructionofil2biologicalfunctionandtregcellsdifferentiationinslepatientsviabindingtoil2